t-lymphoblastic leukemia is potentially curable in some patients with aggressive chemotherapy. The main treatments include drug therapy and allogeneic hematopoietic stem cell transplantation. t-lymphoblastic leukemia is a hematopoietic malignancy that mainly involves t-lymphocytes in the bone marrow and peripheral blood. 1. When t-lymphoblastic leukemia is treated aggressively, there is still a possibility of cure for some patients. Drugs include cyclophosphamide, norethromycin, vincristine, dexamethasone, etc. Targeted drugs such as cedarbenazine can also be used in relapsed patients. 2. When patients achieve complete remission after induction chemotherapy, allogeneic hematopoietic stem cell transplantation should be performed as soon as possible to prolong the survival period. For the same disease, patients have different physical conditions, different risk stratification, different treatment methods, and different prognoses. Standardized treatment should be carried out under the guidance of doctors in order to prolong the survival period and improve the quality of life.